Skip to main content

Table 1 Anthropometric and metabolic data of the whole patient cohort and of patients taking only antihypertensive drugs

From: Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy

 

Whole patient cohort

Patients not taking antidiabetic and/or lipid lowering drugs

 

All patients (n = 129)

Males (n = 46)

Females (n = 83)

All patients (n = 104)

Males (n = 30)

Females (n = 74)

Age (yr)

51.95 ± 10.1

51.4 ± 9.6

52.3 ± 10.5

50.9 ± 10.1

49.4 ± 10.2

51.5 ± 10.1

Weight (kg)

95.8 ± 13.8

102.7 ± 12.3

91.9 ± 13.1**

94.4 ± 13.2

100.2 ± 11.9

92.0 ± 13.1*

Height (cm)

161.8 ± 9.4

171.6 ± 6.7

156.4 ± 5.5*

160.6 ± .8.5

1.7 ± .05

160 ± 5.7**

Systolic Arterial Pressure (mmHg)

130.0 (125–140)

130.0 (125–140)

130.0 (125–140)

130.0 (125–140)

132.0 (128.8–140.0)

130.0 (125–140)

Diaystolic Arterial Pressure (mmHg)

85.0 (75.0–90.0)

85.0 (80.0–91.3)

85.0 (75.0–90.0)

85.0 (75.0–90.0)

85.0 (80.0–91.3)

85.0 (75.0–90.0)

WC (cm)

112.8 ± 10.5

116.1 ± 9.3

110.9 ± 10.7*

111.8 ± 9.8

114.3 ± 8.3

110.7 ± 10.3

BMI (kg/m2)

35.5 (32.4–40.7)

33.7 (32.0–37.6)

36.7 (33.5–42.0)*

35.7 (32.4–40.6)

33.1 (31.8–36.8)

36.9 (33.5–41.5)*

VAI

1.9 (1.2–2.8)

2.1 (1.4–3.1)

1.8 (1.2–2.6)

1.8 (1.2–2.6)

2.0 (1.4–3.5)

1.8 (1.2–2.5)

TBW%

44.9 ± 5.6

50.6 ± 2.9

41.7 ± 3.9**

44.3 ± 5.4

50.8 ± 2.9

41.7 ± 3.8**

ECW%

43.0 ± 4.4

41.4 ± 4.1

43.9 ± 4.4**

43.1 ± 4.5

40.8 ± 3.7

44.1 ± 4.5**

FM%

39.8 ± 7.5

32.5 ± 4.3

43.8 ± 5.6**

40.3 ± 7.6

31.6 ± 4.6

43.8 ± 5.4**

MM%

42.3 ± 8.4

45.0 ± 8.6

40.8 ± 7.9

42.2 ± 8.2

46.2 ± 8.2

40.6 ± 7.6

Plasma Glusose (mg/dl)

98.0 (91.0–107.0)

101.0 (93.5–112.0)

96.0 (88.0–107.0)

96.5 (88.8–106.0)

99.0 (92.0–107.0)

95.0 (87.0–105.5)

Total Cholesterol (mg/dl)

201.0 ± 40.3

196.8 ± 44.1

203.3 ± 38.1

204.8 ± 38.9

210.3 ± 41.7

202.6 ± 37.9

HDL Cholesterol (mg/dl)

49.0 ± 11.4

41.7 ± 9.4

53.0 ± 10.5**

49.8 ± 11.5

41.5 ± 9.4

53.1 ± 10.6**

LDL Cholesterol (mg/dl)

134.2 ± 38.1

118.1 ± 34.8

143.6 ± 37.4

127.9 ± 36.1

133.1 ± 39.7

125.8 ± 34.6

Triglycerides (mg/dl)

131.0 (92.0–169.5)

143.0 (103.3–211.8)

118.0 (85.0–158.0)*

123.0 (88.3–168.8)

148.5 (102.3–227.5)

116.5 (82.5–154.3)*

Triglycerides/HDL ratio

2.7 (1.7–3.8)

3.5 (2.3–5.3)

2.3 (1.5–3.1)**

2.5 (1.6–3.5)

3.5 (2.3–5.8)

116.5 (82.5–154.3)**

SGOT

23.0 (18.0–29.5)

26.0 (21.8–36.0)

21.0 (17.0–25.0)**

23 (18–19)

28.0 (22.0–36.0)

21.0 (17.0–25.0)**

SGPT

28.0 (19.0–43.5)

43.0 (28.0–61.3)

22.0 (16.0–31.0)**

27 (18.5–41)

43.0 (28.0–61.0)

22.0 (16.8–31.0)**

  1. *p < 0.05 vs males
  2. **p < 0.01 vs males